West Nile Virus Core Protein (WNV-Core) (N-Term) antibody

Antigen: West Nile Virus Core Protein (WNV-Core)

Binding Site: N-Term

Clonality: Polyclonal

Host: Rabbit

Reactivity: Please enquire

Application: ELISA

Catalog no.: ABIN238308

Additional Information

Alternative name: West Nile Virus Core Protein

Immunogen: Synthetic peptide corresponding to 15 amino acids near the N-terminal of the West Nile Virus core protein (Genbank accession no. NP_776011)

Format: Liquid

Description: Rabbit anti West Nile Virus Rabbit Antibody to West Nile Virus Core Protein, N-terminal

Specificity: West Nile Virus Core Protein, N-terminal

Application Details

Application Notes: Suitable for use in ELISA (detects 10ng of free peptide at 1ug/ml). Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.

Concentration: 1mg/ml

Purification: Immunoaffinity chromatography

Buffer: PBS. Preservative: 0.02% Sodium azide

Storage: Store (up to 1 year) at 2-8°C. : This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1-1.0%. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains.

Restrictions: For Research Use only

Publications

Yang, Ramanathan, Muthumani et al.: "Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway." in: Emerging infectious diseases, Vol. 8, Issue 12, pp. 1379-84, 2002 (PubMed).

Gould, Fikrig: "West Nile virus: a growing concern?" in: The Journal of clinical investigation, Vol. 113, Issue 8, pp. 1102-7, 2004 (PubMed).

Chu, Ng: "Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells." in: The Journal of biological chemistry, Vol. 279, Issue 52, pp. 54533-41, 2004 (PubMed).

Chu, Rajamanonmani, Li et al.: "Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein." in: The Journal of general virology, Vol. 86, Issue Pt 2, pp. 405-12, 2005 (PubMed).